About Our Company
Spectradyne has commercialized a revolutionary method of measuring sub-micron nanoparticles. Applications include characterizing nanomedicine delivery systems, the measurement of protein aggregation in the drug development industry, virology and in consumer product quality control.
Official winners of the 2023 ISAC CYTO Technology Showcase
Our Team
Jean-Luc Fraikin, CEO
Dr. Fraikin developed the initial NPA technology during his PhD thesis work at UC Santa Barbara in Dr. Cleland’s research group. He has worked in cancer cell biology and biochemistry, and at InDevR led prototyping efforts for a microfluidics-based molecular diagnostic platform. At Spectradyne, Dr Fraikin previously led the development of instrument fluidics, software, and system integration. He is now serving as Spectradyne’s CEO.
Peter Meinhold, Chief Engineer
Dr. Meinhold is an experimental astrophysicist at UC Santa Barbara, and an expert in low noise electronics, signal analysis, and in developing compact instrumentation for space. He is proficient in extracting signals with amplitudes orders of magnitude smaller than the instrument noise. Dr Meinhold has a PhD from UC Berkeley and leads the development of instrument electronics.
Andrew N Cleland, Scientific and Technical Advisor
Dr. Cleland is the John A MacLean Professor of Quantum Engineering Innovation at the University of Chicago, and the recipient of Science magazine’s “Breakthrough of the Year” for 2010. An authority on nanotechnology, nanomechanics and quantum information, Dr. Cleland helps develop Spectradyne’s microfluidic devices as well as next generation instrumentation.
Franklin Monzon, Scientific and Technical Advisor
Dr. Monzon is a co-founder of Spectradyne LLC, and currently advises the company on technical matters related to cartridge design and development.
Ning Wang, Business Advisor
Dr. Wang is currently CEO at Offensive Security, a web security company, and advises Spectradyne LLC on business matters and strategy questions.